Fluoxetine Treatment of Depression in Down Syndrome

Clinical trial NCT05458479 · COMPLETED

Trial details

NCT number: NCT05458479
Sponsor: Massachusetts General Hospital
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Down Syndrome Depression

Start date: 2022-12-05
Primary completion: 2024-02-26
Enrollment: 4

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.